Published: January 21, 2025

Testimonial from our Principal Investigator, Dr Andrés García León

Why should you invest in VERIGRAFT? For the first time ever private persons have the unique opportunity be part of our journey. These are the words from  Dr Andrés García León:

“VERIGRAFT’s technology represents a groundbreaking advance in vascular medicine. For patients with chronic venous insufficiency, this personalized tissue-engineered vein product provides not only hope but the possibility of lasting recovery. We are thrilled to see the potential of this innovation to transform the lives of those who have long suffered from limited treatment options”, says Andrés García León, Head of the Department of Angiology and Vascular Surgery at Virgen de Valme University Hospital, Associate Professor of the University of Seville, and Lead Principal Investigator (PI) for TECVI-1 clinical trial Spain.